We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Louse-Borne Relapsing Fever Surfaces in Europe

By LabMedica International staff writers
Posted on 16 Aug 2015
Borrelia recurrentis, a causative agent of relapsing fever, has for many centuries caused infections of often epidemic proportions and currently the disease is primarily found in north-eastern Africa, but is rarely seen in Europe. More...


Since the infection is exclusively transmitted by body lice and humans are their only host, large scale outbreaks are only expected under circumstances conducive to louse infestation. Lice that feed on infected humans acquire the Borrelia organisms that then multiply in the gut of the louse. When an infected louse feeds on an uninfected human, the organism gains access when the victim crushes the louse or scratches the area where the louse is feeding. B. recurrentis infects the person via mucous membranes and then invades the bloodstream.

Medical microbiologist at the University Medical Center Groningen (The Netherlands) investigated young asylum seekers from Eritrea one who presented with a history of headache, dizziness, right upper quadrant pain, myalgia, and a temperature of 39.3 °C. Another patient resented with general malaise, headache, a temperature of 38.5 °C and cough and his blood tests showed elevated inflammatory parameters, leucocytes count was 12.7 × 109/L, C-reactive protein (CRP) level of 320 mg/L. Malaria was suspected.

Thick and thin blood films did not show malaria parasites and commercial malaria antigen tests were negative. Filamentous unidentified structures were reported in the thick film by the laboratory of the peripheral hospital and louse-borne relapsing fever was suspected. Borrelia recurrentis was confirmed by 16S rDNA polymerase chain reaction (PCR) and sequencing directly from blood. The body louse Pediculus humanus humanus was recovered from their clothing. The patients’ clinical deterioration was provoked by the ceftriaxone administration leading to a severe Jarisch–Herxheimer reaction, so treatment was switched to doxycycline intravenously to reduce the risk of relapse.

The authors concluded that because infections with B. recurrentis pose a significant health risk to other migrants, aid workers, and healthcare personnel and arguably to the general population, screening and delousing should be considered for arriving migrants already at ports of entry into the European Union. The patients may have acquired body lice before arriving in Europe, but transmission of infected lice between migrants after arrival in Europe cannot be ruled out and could pose an additional public health challenge. The study was published on July 30, 2015, in the journal Eurosurveillance.

Related Links:

University Medical Center Groningen



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.